Detroit Tigers, Karmanos Cancer Institute Team Up For 2nd Annual ‘Pink Out The Park’
Buy Tigers Tickets
DETROIT (WWJ) - The Detroit Tigers and the Barbara Ann Karmanos Cancer Institute are teaming up for the second annual Pink Out the Park at the Detroit Tigers vs. Kansas City Royals game Friday, Sept. 13, at 7:08 p.m., at Comerica Park.
The event raises awareness of breast cancer, as well as helps raise funds for breast cancer research at the Karmanos Cancer Institute.
Detroit Tigers fans will have two ticket package opportunities and each ticket purchase will include a Pink Out the Park t-shirt — which will be the only way to get this limited edition t-shirt. Visit www.tigers.com/pinkout for ticket purchase information.
- Ticket Package #1, $29 each, will include a seat in the Upper Box Infield and a Pink Out the Park t-shirt.
- Ticket Package #2, $21 each, will include a seat in the Mezzanine area and a Pink Out the Park t-shirt.
Plus, the first 10,000 fans through the gates will receive a pink bag giveaway.
There will also be kiosks throughout Comerica Park with breast health education materials for fans to take home. Proceeds from two 50/50 raffles at Comerica Park, one to be held Sept. 13 and the other Sept. 14, will also benefit Karmanos’ breast cancer research.
“Everyone knows someone touched by breast cancer,” Tom Brookens, Detroit Tigers third base coach, said in a statement. “Raising awareness of breast cancer to help prevent it, detect it early and develop new treatments has parallels to a winning baseball team: it takes hard work, persistence and teamwork.”
“The Detroit Tigers are proud to team up with the Karmanos Cancer Institute for the second annual Pink Out the Park. Together, with our fans, we will raise awareness and encourage funding for breast cancer research right here at home at the Karmanos Cancer Institute.”
The Barbara Ann Karmanos Cancer Institute is one of only 41 National Cancer Institute-designated comprehensive cancer centers in the country and the only hospital in Michigan solely focused on treating cancer.